Inventor · disambiguated record
Markus Warmuth
Also filed as: WARMUTH MARKUS
14 granted patents·18 pending applications·28 citations·filing 2001–2024
90Inventor score
Files withARROWHEAD PHARMACEUTICALS INC6DONATO NICHOLAS J4ARROWHEAD RES CORP3BARTHE CHRISTOPHE3DIERKS CHRISTINE2
Top patents by PatentIndex Score
32 records- 0186US10287582B2Organic compositions to treat HSF1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2016·Granted May 14, 2019·3 cites·18 claims
- 0285US9540643B2Organic compositions to treat HSF1-related diseasesARROWHEAD RES CORP·Filed 2015·Granted Jan 10, 2017·3 cites·21 claims
- 0385US8481509B2Organic compositions to treat HSF1-related diseasesHINKLE GREGORY·Filed 2012·Granted Jul 9, 2013·6 cites·20 claims
- 0484US8293718B2Organic compositions to treat HSF1-related diseasesHINKLE GREGORY·Filed 2010·Granted Oct 23, 2012·5 cites·51 claims
- 0583US12091661B2Organic compositions to treat HSF1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2022·Granted Sep 17, 2024·0 cites·20 claims
- 0683US9096637B2Organic compositions to treat HSF1-related diseasesARROWHEAD RES CORP·Filed 2013·Granted Aug 4, 2015·3 cites·22 claims
- 0783US2025270555A1Organic compositions to treat beta-catenin-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0882US8623838B2Organic compositions to treat HSF1-related diseasesCHEN JINYUN·Filed 2012·Granted Jan 7, 2014·6 cites·22 claims
- 0980US8119649B2Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2009·Granted Feb 21, 2012·1 cites·6 claims
- 1077US11091761B2Organic compositions to treat HSF1-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2019·Granted Aug 17, 2021·0 cites·20 claims
- 1168US2007149539A1Use of c-src inhibitors alone or in combination with sti571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2007·Application pending·0 cites
- 1264US8268837B2Use of c-Src inhibitors alone or in combination with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2005·Granted Sep 18, 2012·0 cites·1 claims
- 1359US8507471B2Biphenylcarboxamide derivatives as hedgehod pathway modulatorsDIERKS CHRISTINE·Filed 2008·Granted Aug 13, 2013·1 cites·10 claims
- 1459US2004248906A1Use of c-src inhibitors alone or in combination with st1571 for the treatment of leukaemiaFiled 2002·Application pending·0 cites
- 1557US2007027167A1Use of c-Src inhibitors alone or in combinaton with STI571 for the treatment of leukaemiaDONATO NICHOLAS J·Filed 2006·Application pending·0 cites
- 1655US2018282728A1Organic compositions to treat beta-catenin-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 1752US10023862B2Organic compositions to treat beta-catenin-related diseasesHUESKEN DIETER·Filed 2013·Granted Jul 17, 2018·0 cites·9 claims
- 1852US2009191606A1Organic compoundsBARTHE CHRISTOPHE·Filed 2008·Application pending·0 cites
- 1949US2015238515A1Organic compositions to treat kras-related diseasesARROWHEAD RES CORP·Filed 2013·Application pending·0 cites
- 2047US2011129852A1Organic compoundsBARTHE CHRISTOPHE·Filed 2010·Application pending·0 cites
- 2146US2006148058A1Organic compoundsBARTHE CHRISTOPHE·Filed 2006·Application pending·0 cites
- 2246US2013210771A1Methods and compositions for treating cancersNOVARTIS AG·Filed 2013·Application pending·0 cites
- 2346US2010216828A1Methods and compositions for treating cancersDIERKS CHRISTINE·Filed 2008·Application pending·0 cites
- 2446US2003162222A1Method for selecting enzyme inhibitorsFiled 2001·Application pending·0 cites
- 2545US2018153919A1Organic compositions to treat kras-related diseasesARROWHEAD PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 2643US2011021524A1Compositions and methods for treating cancersIRM LLC·Filed 2008·Application pending·0 cites
- 2743US2020190593A1Spliceosome mutations and uses thereofEISAI R&D MAN CO LTD·Filed 2018·Application pending·0 cites
- 2841US2003170851A1Organic compoundsFiled 2002·Application pending·0 cites
- 2940US2012165355A1Methods and compositions for treating cancersWARMUTH MARKUS·Filed 2012·Application pending·0 cites
- 3039US11524009B2Combination comprising at least one spliceosome modulator and at least one inhibitor chosen from BCL2 inhibitors, BCL2/BCLxL inhibitors, and BCLxL inhibitors and methods of useEISAI R&D MAN CO LTD·Filed 2018·Granted Dec 13, 2022·0 cites·34 claims
- 3138US8748428B2Use of a PKC inhibitorSCHULER WALTER·Filed 2011·Granted Jun 10, 2014·0 cites·7 claims
- 3236US2011044991A1Methods and compositions for treating lymphoma and myelomaIRM LLC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Warmuth files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →